View Exam | PowerPak

1.
Patient JS is a 70-year old female who presents to her PCP reporting 2 days of watery diarrhea, vomiting and abdominal pain. She reports 10 or more watery bowel movements each day. She recently finished a 7-day course of clindamycin for a tooth infection prescribed by her dentist. Prior to her tooth infection, she was also prescribed a 7-day course of levofloxacin for a urinary tract infection. Through confirmed laboratory testing ordered by her PCP, she is found to have CDI. WBC were found to be 13,500 cells/mL and her serum creatinine level = 1.1 mg/dL. JS has not been hospitalized within the last year.

Based on patient JS presentation, how would you classify her CDI to report to the National Healthcare Safety Network (NHSN)?

A. Community-Onset B. Community-Onset Healthcare Facility-Associated C. Healthcare Facility-Onset D. Unsure

2. Which of the following are risk factors for CDI in patient JS?

A. Antibiotic use B. Age > 65 C. Exposure D. Choices A and B E. Unsure

3. How would you classify the severity of patient JS's CDI?

A. Initial episode, non-severe B. Initial episode, severe C. Initial episode, fulminant D. First recurrence E. Unsure

4. Which of the following would be an appropriate treatment option for patient JS's CDI?

A. Vancomycin 125 mg 4 times daily for 10 days B. Vancomycin 500 mg 4 times daily by mouth or nasogastric tube C. Metronidazole 500 mg three times daily for 10 days D. Fecal microbiota transplantation E. Unsure

5. Which of the following is true regarding fecal microbiota transplant (FMT)?

A. There are long-term safety data published for FMT. B. Potential candidates for FMT include those with more than 2 recurrences of CDI despite appropriate antibiotic treatment. C. There are large, randomized controlled trials supporting the role of FMT in immunocompromised patients. D. FMT is associated with low treatment success rates. E. Unsure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

2. Which of the following are risk factors for CDI in patient JS?

3. How would you classify the severity of patient JS's CDI?

4. Which of the following would be an appropriate treatment option for patient JS's CDI?

5. Which of the following is true regarding fecal microbiota transplant (FMT)?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

2. Which of the following are risk factors for CDI in patient JS?

3. How would you classify the severity of patient JS's CDI?

4. Which of the following would be an appropriate treatment option for patient JS's CDI?

5. Which of the following is true regarding fecal microbiota transplant (FMT)?

« Return to Activity

Customers who Purchased
this Activity also Purchased